Beijing InnoCare Pharma Tech Co., Ltd.
Works in Dermatology · Genetic & rare · Hematology · Immunology · Neurology · Oncology · Respiratory
Beijing InnoCare Pharma Tech Co., Ltd. is a clinical trial sponsor. It has 26 active clinical trials with 6,172 planned participants, across 7 therapeutic areas. Since 2021 it has completed 10 trials and stopped 0 early.
Trial track record · since 2021
Pipeline · 26 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Beijing InnoCare Pharma Tech Co., Ltd
Beijing InnoCare Pharma Tech Co., Ltd is lead sponsor of 26 active clinical trials on ClinicalTrials.gov, with 6,172 planned participants, in Dermatology, Genetic & rare, Hematology, Immunology and other areas. Since 2021 it has completed 10 trials and stopped 0 early.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Beijing InnoCare Pharma Tech Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-14.
Approve Suite is not affiliated with Beijing InnoCare Pharma Tech Co., Ltd..
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.